| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, rather to transfusiology, specifically to release of haemoglobin solutions purified of stromal components. Method implies that erythrocyte mass is isolated from blood, washed, hemolysed, centrifugated with following supernatant purification from all soluble impurities by anionites, thus supernatant is purified from soluble impurities by addition of anionites as flocculent of particle size 90-160 microns at mass ratio flocculent/haemoglobin = 1.0-4.0, thus pH is maintained at values 6.6-7.2. Invention provides scaled technological process of production of haemoglobin purified of stromal components. ^ EFFECT: development of effective method of production of haemoglobin purified of stromal components. ^ 2 ex, 2 tbl |
